Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03986242
Other study ID # KMUHIRB-F(I)-20180006
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 23, 2018
Est. completion date June 6, 2019

Study information

Verified date June 2019
Source Kaohsiung Medical University Chung-Ho Memorial Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Delayed-onset muscle soreness (DOMS) is an acute micro-trauma or inflammatory response experienced in the most runners; and, it concurrently impairs athletic performance and may increase the risk of sports injury. Alleviating the symptoms of DOMS strategies are various; however, the specific recovery way remains unconcluded. Furthermore, few studies have investigated the effects of vibrating roller on alleviating the symptoms of DOMS and understand the biochemical changes in response to recovery of athletic performance. Therefore, this study hypothesizes that vibration rolling (VR) could provide a self-myofascial release. Meanwhile, vibration exercise could transmit vibration to specific muscle groups to decrease inflammation in corresponding to reduce muscular pain. Therefore, it could offer positive effects including improvements of flexibility, muscle stiffness, visual analog scale (VAS) for pain, jump, and dynamic balance.


Description:

Background: Delayed-onset muscle soreness (DOMS) is an acute micro-trauma or inflammatory response experienced in the most runners; and, it concurrently impairs athletic performance and may increase risk of sports injury. Alleviating the symptoms of DOMS strategies are various; however, the specific recovery way remains unconcluded. Furthermore, few studies have investigated that the effects of vibrating roller on alleviating the symptoms of DOMS, and understand the biochemical changes in response to recovery of athletic performance. Therefore, this study hypothesizes that vibration rolling (VR) could provide self-myofascia release. Meanwhile, vibration exercise could tramsit vibration to speific muscle groups to decrease inflammation in corresponding to reduce muscular pain. Therefore, it could offer positve effects including improvements of flexability, muscle stiffness, visual analog scale (VAS) for pain, jmup, and dynmaic balance. Purpose: To investigate VR, non-vibration rolling (NVR), and static stretching for DOMS on physiological changes and recovery of athletic performance in runners. Methods: Thirty healthy and recreationally adult runners will be voluntarily recruited in the experiment. Participant will be induced DOMS on the treadmill exercise firstly. Next, participants will be matched up and randomly assigned to the VR group, NVR group or static stretching group treatment. Each participant will be instructed to 20-minutes treatment on bilateral muscles including gluteus, anterior, and posterior thighs as well as anterior, and posterior legs. All subjects will receive blood analysis (leukocyte, lymphocyte, creatine kinase, c-reactive protein, interleukin-6) and perform flexibility muscular stiffness, VAS for pain, counter movement jump, Y balance tests on lower limb before exercise and after 24hour and 48 hour interventions. Expected outcomes: VR could effectively alleviate the symptoms of DOMS including decreasing inflammatory biochemical values, decreasing muscular stiffness, reducing muscular pain, and increasing flexibility and jump ability as well as improving dynamic balance on lower limb. This data may provide in alleviating the symptoms of DOMS to healthy populations, athletes, and medical team members.

Key Words: Delayed-onset muscle soreness, vibration therapy, foam roller, stretching exercise, recovery, performance


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date June 6, 2019
Est. primary completion date June 6, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:

- Recruit runners of regular sports ages 20-40

Exclusion Criteria:

- Less than 3 athletes per week.

- Cardiovascular disease.

- History of asthma.

- Musculoskeletal injury within 6 months.

- Previous fracture surgery.

- Neurological symptoms.

- Taking anti-inflammatory drugs.

- Taking high blood pressure and diabetes.

- Bad habits such as smoking, drinking.

- Not being able to cooperate with time detection.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
rolling
use non- vibration rolling and the total time is 20 minutes.
Vibration rolling
use Vibration rolling the vibration frequency is 28 Hz, and the total time is 20 minutes.
Other:
static stretching
static stretching and the total time is 20 minutes.

Locations

Country Name City State
Taiwan Kaohsiung Medical University Kaohsiung

Sponsors (1)

Lead Sponsor Collaborator
Kaohsiung Medical University Chung-Ho Memorial Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary C-reactive protein Mainly used as an indicator of inflammation Change from baseline at 3 days
Primary Interleukin-6 Used as an indicator of inflammation Change from baseline at 3 days
Secondary Flexibility Sports performance by range of motion (unit=degree). Popliteal angle test to test the range of motion the hamstring. =>Amount of knee extension with hip flexed at 90ยบ
Ely's test to test the range of motion the rectus femoris.
=>The therapist is standing next to the patient, at the side of the leg that will be tested.
One hand should be on the lower back, the other holding the leg at the heel. Passively flex the knee in a rapid fashion. The heel should touch the buttocks. Test both sides for comparison. The test is positive when the heel cannot touch the buttocks, the hip of the tested side rises up from the table, the patient feels pain or tingling in the back or legs.
Change from baseline at 3 days
Secondary Visual analog scale for pain Measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured.
providing a range of scores from 0-10, the following cut points on the pain VAS have been recommended: no pain (0), mild pain(1-3), moderate pain (4-6), and severe pain (>6).
Change from baseline at 3 days
Secondary Counter movement jump The countermovement jump (CMJ) is a simple, practical, valid, and very reliable measure of lower-body power.
As a consequence, it is no surprise that this has become a cornerstone test for many strength and conditioning coaches and sports scientists.
The CMJ has been shown to be the most reliable measure of lower-body power compared to other jump tests.
Use My jump 2 APP to measure jump height (unit=cent). <30 cm=the subject was fatigue, >30 cm=the subject was normal.
Change from baseline at 3 days
Secondary Y balance test The YBT requires the athlete to balance on one leg whilst simultaneously reaching as far as possible with the other leg in three separate directions: anterior, posterolateral, and posteromedial.
Therefore, this test measures the athlete's strength, stability and balance in various directions.
The YBT composite score is calculated by summing the 3 reach directions and normalizing the results to the lower limb length, whereas asymmetry is the difference between right and left limb reach (1) - this is explained in greater detail in the scoring system section.
Change from baseline at 3 days
Secondary Muscle stiffness Use Myoton PRO instrument to test the muscle stiffness. The method of measurement consists of recording damped natural oscillation of soft biological tissue in the form of an acceleration signal and the subsequent simultaneous computation of the parameters of State of Tension, Biomechanical and Viscoelastic properties.
Damped natural oscillation is induced by an exterior, low force quick-release mechanical impulse under constant pre-load.
The test muscle : Quadriceps, Hamstring, Gastrocnemius, Tibialis anterior muscle.
Change from baseline at 3 days
See also
  Status Clinical Trial Phase
Completed NCT03961022 - Effects of ReWin(d) Supplementation on the Recovery of DOMS Induced by Acute Exercice Phase 2